ArticleJournal of cellular and molecular medicine2022

Systematic pan-cancer analysis identifies RBM39 as an immunological and prognostic biomarker.

Rui Zhang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.